Thrivent Financial for Lutherans
Position in RCUS — Arcus Biosciences, Inc.
CIK 314984
Minneapolis, MN
Position in RCUS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,509,300
-$406,464 QoQ
Shares Held
69,875
-13.1% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Thrivent Financial for Lutherans holds $270,833,554 across 48 Biotechnology names. RCUS ranks #28 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
1,568,627 | $67,278,411 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
627,699 | $35,458,716 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
75,977 | $33,926,767 | |
| 4 | RPRX |
Royalty Pharma plc
|
499,167 | $23,945,040 | |
| 5 | TECH |
BIO-TECHNE Corp
|
302,934 | $15,831,330 | |
| 6 | ARGX |
Argenx SE
|
12,682 | $9,261,030 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
20,470 | $6,772,908 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,440 | $6,521,080 |
All Filings in RCUS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,509,300 | 69,875 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,915,764 | 80,393 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $678,762 | 49,909 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $405,616 | 49,830 | Shares | Sole | 2025-08-26 | |
| 2025-03-31 | $388,017 | 49,429 | Shares | Sole | 2025-08-26 | |
| 2024-12-31 | $621,404 | 41,733 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $647,684 | 42,360 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $689,964 | 45,303 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $885,377 | 46,895 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $917,296 | 48,026 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $880,842 | 49,072 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,022,669 | 50,353 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $942,369 | 51,665 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $1,105,883 | 53,476 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,404,975 | 53,707 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,160,546 | 45,799 | Shares | Sole | 2022-08-16 | |
| No filing history on record for this holder in this stock. | ||||||